$HLF

HERBALIFE LTD. (HLF): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

HERBALIFE LTD. (HLF) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 31, 2026, the Company announced that Stephan Gratziani will transition from his role as Chief Executive Officer,

Original reporting
Published Aug 31, 2026, 10:50 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 31, 2026, 11:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$HLF
Neutral
medium confidence
Mentioned
$HLF
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HLFNeutralMed
01

Why it matters

The filing provides the first public notice of the leadership change, a material corporate event.

02

Market read

Executive change is a corporate action that may influence stock price and investor positioning.

03

What to watch

Potential succession plan details and interim management arrangements are not disclosed.

Relevance 6/10Novelty 7/10Timing: effective Oct 31 2026

Background

Herbalife filed a Form 8‑K reporting the planned CEO transition.

Company-level read

Ticker impact

$HLFNeutralMedium confidence
Context

Herbalife announced CEO Stephan Gratziani will step down effective Oct 31, 2026.

Expected impact

Potential short-term volatility; modest downside risk if transition is viewed negatively.

Evidence & confidence

CEO departures are material corporate actions but the transition is planned and not abrupt.

Market effects

May signal broader leadership reshuffle in the nutrition and weight‑loss sector.

Limited to U.S. listed consumer‑goods investors.

Low global impact; primarily affects Herbalife shareholders.

Counterpoint

The CEO exit could open opportunities for a strategic overhaul and upside if a new leader drives growth.

Key entities

  • Herbalife Ltd.

    Global nutrition and weight‑loss products company.

  • Stephan Gratziani

    Current CEO stepping down.

Related articles

$HLFHigh

Why Herbalife (HLF) Stock Is Nosediving

Herbalife (HLF) stock fell 13.2% after CEO Stephan Gratziani announced his departure, effective October 31, 2026. CFO John DeSimone will serve as interim CEO. The company's shares are down 14.2% YTD and 44.9% from their 52-week high. Argus Research previously upgraded HLF to 'Buy' with a $15 price target, citing expected revenue growth from new products.

$HLFHigh

Why is Herbalife stock tumbling today?

Herbalife (HLF) stock fell 12.7% after announcing CEO Stephan Gratziani will step down by October 31, 2026, with CFO John DeSimone as interim CEO. The company reaffirmed its Q3 and full-year 2026 financial guidance, projecting net sales growth of 0.5% to 4.5% and adjusted EBITDA of $160M to $180M. Broader market declines and geopolitical tensions also contributed to the sell-off.

$HLFMedAI 8/10

Herbalife stock tumbles as CEO Gratziani to step down in 2026

Herbalife Ltd (NYSE: HLF) shares dropped 12.5% after announcing CEO Stephan Gratziani will step down in 2026. He will transition to a consultant role, and CFO John DeSimone will serve as interim CEO. The company reaffirmed its 2026 financial guidance, expecting YoY net sales growth and adjusted EBITDA of $670M-$690M for the full year.

$HLFMedAI 8/10

Herbalife (NYSE:HLF) Beats Q2 CY2026 Sales Expectations

Herbalife (NYSE:HLF) reported Q2 CY2026 revenue of $1.33 billion, up 5.4% year on year and about 1.5% above Wall Street estimates, according to the company. It guided next-quarter revenue near $1.31 billion. Non-GAAP EPS was $0.51, missing consensus by 4.9%. Shares fell 3.4% to $12.16 after results.

$HLFMed

HERBALIFE LTD. (HLF): Results of Operations and Financial Condition

HERBALIFE LTD. (HLF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CONFIDENTIAL & PRIVILEGED Herbalife Reports Second Quarter Net Sales Growth; Marks Fourth Consecutive Quarter of Topline Expansion; Net Sales and Adjusted EBITDA 1 Exceed Guidance Excluding FX Headwinds 2 Advances Personalized Nutrition with Bioniq launch; CFO John D